Ramy Shaaban · A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
Follow
Article1 min read·Published Jul 2026

A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Jul 2026 · 1 min read

In brief

In brief

Systematic review and meta-analysis evaluating the efficacy and safety of chloroquine and hydroxychloroquine, either as monotherapy or combined with azithromycin, for COVID-19 treatment. Synthesizes evidence from observational studies and randomized trials to assess therapeutic outcomes and inform clinical decision-making during the pandemic.

Written by the GCMD Library team from the article.

Ramy Shaaban

Many recent studies have investigated the role of either Chloroquine (CQ) or Hydroxychloroquine (HCQ) alone or in combination with azithromycin (AZM) in the management of the emerging coronavirus. This systematic review and meta-analysis of either published or preprint observational studies or rando …

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →